Furthermore, blockade of ErbB3 expression using an artificial transcription factor, E3, inhibits breast cancer cell growth and targeted downregulation of ErbB4, using either ribozymes or small interfering RNA, can reduce the growth of MCF-7 and T47D cell lines both in vitro and in vivo [23,40]. Here, ERBB3 is linked to breast carcinoma.